Tarsus Pharmaceuticals (TARS) Competitor Comparison
We are evaluating the key criteria listed to compare Tarsus Pharmaceuticals (TARS) against its competitors in the Biotechnology industry.
Market Capitalization
109 / 368Gross Profits
169 / 278Total Revenue
172 / 300EBITDA
219 / 337Free Cashflow
231 / 352Quick Ratio
69 / 357Earnings per Share
293 / 359Dividend yield
0 / 6Total Cash
133 / 358Performance 3 years
57 / 368Performance 5 years
49 / 368Performance 10 years
43 / 368Linearity 3 years
335 / 368Linearity 5 years
319 / 368Linearity 10 years
324 / 368Total Rank
281 / 368Dividend Rank
282 / 368Valuation Rank
255 / 368Piotroski Rank
323 / 368Muliplier Rank
216 / 368Market Capitalization - TARS ranking 109 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.